Cisplatin
InterventionPubChem 5702198MeSH D002945
Trial sponsors
Company54 trialsPhase 428,616 people
Company23 trialsPhase 49,219 people
Company14 trialsPhase 43,595 people
Nanjing NingQi Medicine Science and Technology
Company3 trialsPhase 41,168 people
Company2 trialsPhase 4254 people
Nanjing Luye Sike Pharmaceutical
Company1 trialPhase 4536 people
Company59 trialsPhase 314,206 people
Company35 trialsPhase 314,963 people
Latest
4Cancer MedicineHumans
Older patients had hearing loss at lower chemotherapy doses
An observational study of 316 people with head and neck cancer tracked hearing during treatment with cisplatin, a chemotherapy drug.An observational study of 316 people with head and neck cancer tracked hearing during treatment with cisplatin, a chemotherapy drug.